203 related articles for article (PubMed ID: 30418430)
21. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
[TBL] [Abstract][Full Text] [Related]
22. Renal Transplant in Elderly End-Stage Renal Disease Patients: Impact of Comorbidities and Posttransplant Adverse Events on Outcomes.
Hamdy MY; El Aggan H; El Gohary I; Halawa A
Exp Clin Transplant; 2024 Feb; 22(2):93-102. PubMed ID: 38511980
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
Opelz G; Daniel V; Naujokat C; Döhler B
Transplantation; 2009 Oct; 88(8):962-7. PubMed ID: 19855238
[TBL] [Abstract][Full Text] [Related]
24. Pretransplant Renal Arterial Vasculopathy of Donor Predicts Poor Renal Allograft Survival.
Özdemir BH; Özdemir FN; Börcek P; Sercan Ç; Özdemir G; Ayvazoğlu Soy EH; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):41-46. PubMed ID: 29527990
[TBL] [Abstract][Full Text] [Related]
25. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies.
Kauffman HM; Cherikh WS; Cheng Y; Hanto DW; Kahan BD
Transplantation; 2005 Oct; 80(7):883-9. PubMed ID: 16249734
[TBL] [Abstract][Full Text] [Related]
26. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
27. Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous Cancer.
Viecelli AK; Lim WH; Macaskill P; Chapman JR; Craig JC; Clayton P; Cohney S; Carroll R; Wong G
Transplantation; 2015 Dec; 99(12):2586-92. PubMed ID: 26102612
[TBL] [Abstract][Full Text] [Related]
28. Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients.
Molnar MZ; Kovesdy CP; Bunnapradist S; Streja E; Mehrotra R; Krishnan M; Nissenson AR; Kalantar-Zadeh K
Am J Transplant; 2011 May; 11(5):1006-15. PubMed ID: 21449945
[TBL] [Abstract][Full Text] [Related]
29. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
[TBL] [Abstract][Full Text] [Related]
30. Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival.
Eide IA; Halden TAS; Hartmann A; Dahle DO; Åsberg A; Jenssen T
Transplantation; 2017 Jun; 101(6):1282-1289. PubMed ID: 27362306
[TBL] [Abstract][Full Text] [Related]
31. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
[TBL] [Abstract][Full Text] [Related]
32. Cumulative cancer incidence and mortality after kidney transplantation in Japan: A long-term multicenter cohort study.
Imamura R; Nakazawa S; Yamanaka K; Kakuta Y; Tsutahara K; Taniguchi A; Kawamura M; Kato T; Abe T; Uemura M; Takao T; Kishikawa H; Nonomura N
Cancer Med; 2021 Apr; 10(7):2205-2215. PubMed ID: 33314709
[TBL] [Abstract][Full Text] [Related]
33. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
Chen JH; Mao YY; He Q; Wu JY; Lv R
Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
[TBL] [Abstract][Full Text] [Related]
34. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
Huang Y; Ramon D; Luan FL; Sung R; Samaniego M
Clin Transpl; 2012; ():247-56. PubMed ID: 23721029
[TBL] [Abstract][Full Text] [Related]
35. Association of pretransplant soluble glycoprotein 130 (sgp130) plasma levels and posttransplant acute tubular necrosis in renal transplant recipients.
Sadeghi M; Daniel V; Lahdou I; Döhler B; Naujokat C; Renner FC; Weimer R; Fonouni H; Mehrabi A; Schmidt J; Schenk M; Zeier M; Opelz G
Transplantation; 2009 Jul; 88(2):266-71. PubMed ID: 19623024
[TBL] [Abstract][Full Text] [Related]
36. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.
Chavalitdhamrong D; Gill J; Takemoto S; Madhira BR; Cho YW; Shah T; Bunnapradist S
Transplantation; 2008 Jun; 85(11):1573-9. PubMed ID: 18551062
[TBL] [Abstract][Full Text] [Related]
37. Age is an important predictor of kidney transplantation outcome.
Veroux M; Grosso G; Corona D; Mistretta A; Giaquinta A; Giuffrida G; Sinagra N; Veroux P
Nephrol Dial Transplant; 2012 Apr; 27(4):1663-71. PubMed ID: 21926404
[TBL] [Abstract][Full Text] [Related]
38. Changing pattern and safety of pretransplant malignancy in kidney transplant recipients.
Ban TH; Park WY; Jin K; Han S; Chung BH; Park SC; Choi BS; Park CW; Yun SS; Kim YS; Yang CW
Kidney Res Clin Pract; 2019 Dec; 38(4):509-516. PubMed ID: 31640307
[TBL] [Abstract][Full Text] [Related]
39. Predictive Score for Posttransplantation Outcomes.
Molnar MZ; Nguyen DV; Chen Y; Ravel V; Streja E; Krishnan M; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
Transplantation; 2017 Jun; 101(6):1353-1364. PubMed ID: 27391198
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes of pediatric kidney transplant recipients with a pretransplant malignancy.
Serrano OK; Gannon A; Olowofela AS; Reddy A; Berglund D; Matas AJ
Pediatr Transplant; 2019 Nov; 23(7):e13557. PubMed ID: 31407868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
